ONON stock is resuming its rally and is in a buy zone of a flat base. On Holding reported a mixed earnings report Tuesday.

JD stock fell early Thursday even though the Chinese e-commerce giant beat third-quarter earnings expectations.

It’s the first time that the IBD 50 would be an investable product. But early investors into the fund didn’t get the kind of performance they were hoping for. From the fund’s launch in April ...

IBD named Nu as Stock Of The Day on Oct. 28 ... Both Warren Buffett and Cathie Wood own Nu stock, though they are very ...

Aeglea Biotherapeutics Inc. ( (SYRE) ) has released its Q3 earnings. Here is a breakdown of the information Aeglea Biotherapeutics Inc.

Vertiv stock shares have risen 175% as of November 11. Last month, the data center hardware and services provider exceeded ...

Investors expressed concern over the revenue growth guidance ... further off its 200-day long-term support level. The stock’s ...

Google is making AI pay off in the form of faster growth and higher profitability. If the company keeps beating expectations, ...

Living with IBD and having symptoms of Inflammatory Bowel Disease is hard in and of itself. It tends to create a lot of stress for people. When I'm looking at someone who's really, really starting ...

"Their novel approach to the BLT1 pathway holds great promise for addressing unmet needs in IBD and cancer. I am excited to contribute ... Thetis is supported by private investors, the National ...

Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectableCompany ...

VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis.